oral glp 1 pfizer to discontinue danuglipron, its GLP-1 pill for obesity| STAT Pfizer Stops Work on Oral

It is not known if TOUJEO may harm your unborn or breastfeeding baby

Pfizer's decision to halt development of the drug came after "a review of the totality of information, including all clinical data generated to date for danuglipron and recent input from regulators," according to a release

Additionally, the translational relevance of these findings likely differs by disease phenotype

Despite these encouraging findings, further research is still needed to understand more thoroughly the mechanisms by which GLP-1RAs may mediate stroke protection specifically in the human diabetic brain

2011;23(12):H41-56

She was never a good water-drinker to begin with and was dehydrated on top of it